Proteinuria

Gene: ANLN

Amber List (moderate evidence)

ANLN (anillin actin binding protein)
EnsemblGeneIds (GRCh38): ENSG00000011426
EnsemblGeneIds (GRCh37): ENSG00000011426
OMIM: 616027, Gene2Phenotype
ANLN is in 2 panels

4 reviews

Melanie Marty (Victorian Clinical Genetics Services)

I don't know

Gbadegesin et al (2014); Hall et al (2018) 2 x families reported with FSGS (USA) and missense variants G618C (v4: absent) and R431C (v4: 63 hets, 0 hom). R431C was identified in 6 affected family members and absent in 6 unaffected family members. G618C was present in the proband and absent in 4 unaffected family members, the other 2 affected individuals from this family were not genotyped (deceased). Missense demostrated as LoF with both in vitro and in vivo (zebrafish). R431C was shown to disrupt interaction with CD2AP (primarily LoF effect), causing downstream hyperactivation of the PI3K/AKT/mTOR/Rac1 signaling pathway, which drives podocytes hypermotility.

Geminiganesan et al (2021) 1 x 2 year old child (India) with early-onset steroid resistant nephrotic syndrome, whole-exome sequencing and genome-wide linkage studies, a missense variant in ANLN was identified p.Thr821Met (v4: 508 hets, 0 hom).

Zhang et al (2023) 3 x children with steroid resistant nephrotic syndrome (China). 2 x missense (p.M1099I - LP (v4:1 het, 0 hom), p.S140T - VUS (v4: 6 hets, 0 hom) and 1 x stop gain reported p.R39X - LP ( v4: 1 het, 0 hom).

Lin et al (2023) 3 x unrelated individuals with missense E841K (China, v4: 618 hets, 2 hom). In famly A the variant was de novo, in family 2 only the proband as tested, in family 3 the variant was inherited from an affected father. 4 x unaffected individuals did not have the variant. Knockout mouse model inconclusive, did not show any effect until 36 weeks. Zebrafish model was also inconclusive.
Created: 23 Sep 2025, 10:33 a.m. | Last Modified: 23 Sep 2025, 10:33 a.m.
Panel Version: 0.229

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Phenotypes
Focal segmental glomerulosclerosis 8, MIM#616032

Publications

Michelle Torres (Victorian Clinical Genetics Services)

I don't know

Segregated in 2 families reported with FSGS, functional were performed (PMID: 24676636; 30002222 - same group). However, the segregation of G618C is not informative as the only affected tested was the proband, the other 2 were not genotyped (deceased). In addition, the R431C has 5 hets in the pop, as well as an alternative change. Therefore, the evidence for pathogenicity of both variants is conflicting, and the association with FSGS remains NOT established.
Created: 15 May 2020, 6:19 p.m. | Last Modified: 15 May 2020, 6:19 p.m.
Panel Version: 0.109

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Phenotypes
Focal segmental glomerulosclerosis 8 616032

Publications

Zornitza Stark (Victorian Clinical Genetics Services)

I don't know

2 families report with functional evidence.
Created: 9 Jan 2020, 8:49 p.m. | Last Modified: 9 Jan 2020, 8:49 p.m.
Panel Version: 0.732

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Phenotypes
Focal segmental glomerulosclerosis 8, OMIM #616032

Publications

Chirag Patel (Genetic Health Queensland)

I don't know

2 families report with functional evidence.
Created: 9 Jan 2020, 2:19 p.m. | Last Modified: 9 Jan 2020, 2:19 p.m.
Panel Version: 0.67

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Phenotypes
Focal segmental glomerulosclerosis 8, OMIM #616032

Publications

Details

Mode of Inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Sources
  • Expert Review Amber
  • Expert Review Amber
  • Victorian Clinical Genetics Services
  • Victorian Clinical Genetics Services
Phenotypes
  • Focal segmental glomerulosclerosis 8, OMIM #616032
OMIM
616027
Clinvar variants
Variants in ANLN
Penetrance
None
Publications
Panels with this gene

History Filter Activity

23 Sep 2025, Gel status: 2

Set publications

Zornitza Stark (Victorian Clinical Genetics Services)

Publications for gene: ANLN were set to 24676636; 30002222

14 Jan 2020, Gel status: 2

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services)

Gene: anln has been classified as Amber List (Moderate Evidence).

14 Jan 2020, Gel status: 2

Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services)

Phenotypes for gene: ANLN were changed from Focal segmental glomerulosclerosis 8, OMIM #616032 to Focal segmental glomerulosclerosis 8, OMIM #616032

14 Jan 2020, Gel status: 2

Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services)

Phenotypes for gene: ANLN were changed from to Focal segmental glomerulosclerosis 8, OMIM #616032

14 Jan 2020, Gel status: 2

Set publications

Zornitza Stark (Victorian Clinical Genetics Services)

Publications for gene: ANLN were set to

14 Jan 2020, Gel status: 2

Set mode of inheritance

Zornitza Stark (Victorian Clinical Genetics Services)

Mode of inheritance for gene: ANLN was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

9 Jan 2020, Gel status: 2

Entity classified by Genomics England curator

Chirag Patel (Genetic Health Queensland)

Gene: anln has been classified as Amber List (Moderate Evidence).

9 Jan 2020, Gel status: 2

Entity classified by Genomics England curator

Chirag Patel (Genetic Health Queensland)

Gene: anln has been classified as Amber List (Moderate Evidence).

9 Jan 2020, Gel status: 2

Entity classified by Genomics England curator

Chirag Patel (Genetic Health Queensland)

Gene: anln has been classified as Amber List (Moderate Evidence).

9 Jan 2020, Gel status: 2

Entity classified by Genomics England curator

Chirag Patel (Genetic Health Queensland)

Gene: anln has been classified as Amber List (Moderate Evidence).

9 Jan 2020, Gel status: 2

Entity classified by Genomics England curator

Chirag Patel (Genetic Health Queensland)

Gene: anln has been classified as Amber List (Moderate Evidence).

9 Jan 2020, Gel status: 2

Entity classified by Genomics England curator

Chirag Patel (Genetic Health Queensland)

Gene: anln has been classified as Amber List (Moderate Evidence).

9 Jan 2020, Gel status: 2

Entity classified by Genomics England curator

Chirag Patel (Genetic Health Queensland)

Gene: anln has been classified as Amber List (Moderate Evidence).

17 Nov 2019, Gel status: 3

Created, Added New Source, Set mode of inheritance

Zornitza Stark (Victorian Clinical Genetics Services)

gene: ANLN was added gene: ANLN was added to Nephrotic Syndrome_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services Mode of inheritance for gene: ANLN was set to Unknown